- Exchange: OTC US
- Sector: Consumer, Non-cyclical
- Industry: Healthcare-Products
- Sub-Industry: Medical Instruments
AdvanSource Biomaterials Corp
+ Add to WatchlistASNB:US
0.0611 USD 0.0033 5.12%As of 09:49:15 ET on 05/20/2013.
Snapshot for AdvanSource Biomaterials Corp (ASNB)
| Open: | 0.0611 | Day's Range: | 0.0611 - 0.0611 | Volume: | 27,670 |
|---|---|---|---|---|---|
| Previous Close: | 0.0644 | 52wk Range: | 0.0101 - 0.1318 | 1-Yr Rtn: | +190.95% |
Key Statistics for ASNB
| Current P/E Ratio (ttm) | - |
|---|---|
| Estimated P/E(-) | - |
| Relative P/E vs. SPX | - |
| Earnings Per Share (ttm) | -0.0600 |
| Est. EPS | - |
| Est. PEG Ratio | - |
| Market Cap (M USD) | 1.38 |
| Shares Outstanding (M) | 21.49 |
| 30 Day Average Volume | 12,789 |
| Price/Book (mrq) | 1.2811 |
| Price/Sale (ttm) | 0.6156 |
| Dividend Indicated Gross Yield | -% |
| Cash Dividend | - |
| Last Dividend | |
| 5 Year Dividend Growth | - |
| Next Earnings Announcement | 07/11/2013 |
mrq = Most Recent Quarter; ttm = Trailing Twelve Months
Income Statement for ASNB
Company Profile & Key Executives for ASNB
AdvanSource Biomaterials Corp. develops polymer materials, which provides characteristics in the design and development of medical devices. The Company's biomaterials are used in devices that are designed for treating a range of anatomical sites and disease states.
| William J O'Neill JrChairman | Michael F AdamsPresident/CEO/Secretary |
| David C VolpeActing Chief Financial Officer |
Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.
Sponsored Financial Commentaries
Advertisement
Top Forex Trading Resources
-
ASNB News
-
Industry News
No stories found
Advertisement
- 1
- 2
- 3
- 4
- 5
Advertisement
Sponsored Links
Advertisements
Rate this Page